Malik Kemal - Insider Non-Derivative Transactions at Cartesian Therapeutics, Inc. (RNAC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 1, 2024, Malik Kemal's relationship to Cartesian Therapeutics, Inc. (RNAC) is Director, and currently has 5,933 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RNAC insiders.
Data Source: SEC.
Malik Kemal - Insider Non-Derivative Transactions at RNAC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 2, 2024 | Acquisition -- (Common Stock) | 5933 | 0 | 5933 |